(Q44108156)

29 November 2017

title

Use of serial FDG PET to measure the response of bone-dominant breast cancer to therapy (English)

1 reference

29 November 2017

Stephanie E Stafford

1

1 reference

29 November 2017

Julie R Gralow

2

1 reference

29 November 2017

Erin K Schubert

3

1 reference

29 November 2017

Kristine J Rinn

4

1 reference

29 November 2017

Lisa K Dunnwald

5

1 reference

29 November 2017

Robert B Livingston

6

1 reference

29 November 2017

David A Mankoff

7

1 reference

29 November 2017

publication date

1 August 2002

1 reference

29 November 2017

1 reference

29 November 2017

volume

9

1 reference

29 November 2017

issue

8

1 reference

29 November 2017

page(s)

913-921

1 reference

Bone metastases: pathophysiology and management policy

29 November 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Worsening bone scan in the evaluation of antitumor response during hormonal therapy of breast cancer.

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Detection of bone metastases in breast cancer by 18FDG PET: differing metabolic activity in osteoblastic and osteolytic lesions

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Positron-emission tomographic imaging of cancer: glucose metabolism and beyond

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

The Application of Positron Emission Tomographie Imaging With Fluorodeoxyglucose to the Evaluation of Breast Disease

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Positron emission tomography using [(18)F]-fluorodeoxy-D-glucose to predict the pathologic response of breast cancer to primary chemotherapy

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Metabolic monitoring of breast cancer chemohormonotherapy using positron emission tomography: initial evaluation

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Positron emission tomography using [(18)F]Fluorodeoxyglucose for monitoring primary chemotherapy in breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

2000 update of recommendations for the use of tumor markers in breast and colorectal cancer: clinical practice guidelines of the American Society of Clinical Oncology

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

The epithelial mucin, MUC1, of milk, mammary gland and other tissues

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

Metabolic flare: indicator of hormone responsiveness in advanced breast cancer

1 reference

https://api.crossref.org/works/10.1016%2FS1076-6332%2803%2980461-0

7 January 2021

10.1016/S1076-6332(03)80461-0

Identifiers

DOI

1 reference

29 November 2017

1 reference